Hansson
Hansson is a prominent researcher in the field of neurology, known for his contributions to understanding Alzheimer's disease. He has emphasized the importance of blood biomarkers in diagnosing and staging the disease, advocating for the integration of innovative technologies to enhance patient care and treatment strategies.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Paraguay | 1 | 7.00 | 0.06% | +0% | 7,132,538 | 3,965 | $38,000 | 21$ |
| Bolivia | 1 | 7.00 | 0.06% | +0% | 11,673,021 | 6,891 | $40,000 | 24$ |
| Totals | 2 | 18,805,559 | 10,856 | $78,000 | 45$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Bolivia:
Hansson believes that the number and variety of medications available for Alzheimer's could soon increase.
7
Paraguay:
Hansson discusses the potential use of p-tau217 and MTBR-tau243 in diagnosing Alzheimer's disease.
7